Cargando…

PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis

BACKGROUND: The plasminogen activator inhibitor-1 (PAI-1) is expressed in many cancer cell types and allows the modulation of cancer growth, invasion and angiogenesis. To date, studies investigated the association between a functional polymorphism in PAI-1 (4G/5G) and risk of cancer have shown inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shangqian, Cao, Qiang, Wang, Xiaoxiang, Li, Bingjie, Tang, Min, Yuan, Wanqing, Fang, Jianzheng, Qian, Jian, Qin, Chao, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577655/ https://www.ncbi.nlm.nih.gov/pubmed/23437240 http://dx.doi.org/10.1371/journal.pone.0056797

Ejemplares similares

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis
por: XU, XIN, et al.
Publicado: (2012)

Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco
por: Hassani Idrissi, Hind, et al.
Publicado: (2016)

PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study
por: Xu, Kuanfeng, et al.
Publicado: (2013)

Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population
por: Valdés-Alvarado, Emmanuel, et al.
Publicado: (2019)

Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms
por: Sun, Wei, et al.
Publicado: (2013)

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
por: Lorente, Leonardo, et al.
Publicado: (2015)

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
por: Wang, Ziran, et al.
Publicado: (2022)

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
por: Živković, Maja, et al.
Publicado: (2014)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

PSCA s2294008 C>T and rs2976392 G>A polymorphisms contribute to cancer susceptibility: evidence from published studies
por: Gu, Yong, et al.
Publicado: (2015)

In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time
por: de Lange, Zelda, et al.
Publicado: (2013)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction
por: Parpugga, Tajinder Kumar, et al.
Publicado: (2015)

The G Allele of CaSR R990G Polymorphism Increases Susceptibility to Urolithiasis and Hypercalciuria: Evidences from a Comprehensive Meta-Analysis
por: Liu, Kang, et al.
Publicado: (2015)

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
por: Mairuhu, ATA, et al.
Publicado: (2005)

The -844 G>A PAI-1 Polymorphism Is Associated with Acute Coronary Syndrome in Mexican Population
por: García-González, Ilian Janet, et al.
Publicado: (2015)

Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients
por: Wang, Baoyan, et al.
Publicado: (2021)

Association Between - 675 ID, 4G/5G PAI-1 Gene Polymorphism and Pregnancy Loss: A Systematic Review
por: Adler, Grazyna, et al.
Publicado: (2018)

The Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma Phenotype
por: Lampalo, Marina, et al.
Publicado: (2018)

Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms
por: Zhang, Xueya, et al.
Publicado: (2020)

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
por: Wang, Yongjie, et al.
Publicado: (2014)

Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
por: Kumar, Sunil, et al.
Publicado: (2021)

AB210. The cytochrome P4501A1 gene polymorphisms and idiopathic male infertility risk: a meta-analysis
por: Fang, Jianzheng, et al.
Publicado: (2014)

Association of the Glutathione S-Transferase M1, T1 Polymorphisms with Cancer: Evidence from a Meta-Analysis
por: Fang, Jianzheng, et al.
Publicado: (2013)

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children
por: De la Cruz-Mosso, Ulises, et al.
Publicado: (2012)

Circulating Levels of PAI-1 and SERPINE1 4G/4G Polymorphism Are Predictive of Poor Prognosis in HCC Patients Undergoing TACE()
por: Divella, Rosa, et al.
Publicado: (2015)

XPG rs873601 G>A contributes to uterine leiomyoma susceptibility in a Southern Chinese population
por: Liu, Zhi-Qin, et al.
Publicado: (2018)

Pauli Manuscript Collection: A. Pais and G. E. Uhlenbeck
por: Pauli, Wolfgang
Publicado: (2002)

Cyclin D1 G870A Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Systematic Review of 22 Case-Control Studies
por: Yang, Yongzhi, et al.
Publicado: (2012)

Association of MTRR A66G polymorphism with cancer susceptibility: Evidence from 85 studies
por: Wang, Ping, et al.
Publicado: (2017)

AB211. Association of the glutathione S-transferase M1, T1 polymorphisms with cancer: evidence from a meta-analysis
por: Fang, Jianzheng, et al.
Publicado: (2014)

Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women
por: Mary, Maniraja Jesintha, et al.
Publicado: (2017)

PIN1 promoter polymorphism (−842 G>C) contributes to a decreased risk of cancer: Evidence from meta-analysis
por: TAO, LIANG-JUN, et al.
Publicado: (2014)

Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study
por: Yousuf, Syed Douhath, et al.
Publicado: (2022)

Contribution of MTR A2756G polymorphism and MTRR A66G polymorphism to the risk of idiopathic male infertility
por: Ren, Zheng-Ju, et al.
Publicado: (2019)

Association of Fas -1377 G/A Polymorphism with Susceptibility to Cancer
por: Geng, Peiliang, et al.
Publicado: (2014)

A meta-analysis of the association of the ACE I/D and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Iranian women: Are the investigations adequate?
por: Dastgheib, Seyed Alireza, et al.
Publicado: (2021)

Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population
por: Tang, Jianjun, et al.
Publicado: (2016)

The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility
por: Niebudek, Katarzyna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_67a99qar8tmhd49kcnu0uedaj5